Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries.

Michael McPherson1, Yingfei Yang, Philip W Hammond

  • 1Phylos, Inc., 128 Spring Street, Lexington, MA 02421, USA. mmcpherson@phylos.com

Chemistry & Biology
|June 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of aging biomarkers and reproductive hormones in the association between microcystin-LR exposure and semen quality.

Journal of hazardous materials·2025
Same author

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Pressure, Temperature, and Water Vapor Dependencies of the Bimolecular Rate Coefficients for the Reaction OH + NO + M → HONO + M.

The journal of physical chemistry. A·2025
Same author

Short Chain Chlorinated Paraffins Impaired Spermatogenesis Process in Mice via Inhibiting α-KG/TET Enzyme Activity.

Environmental science & technology·2024
Same author

Vasicine attenuates atherosclerosis via lipid regulation, inflammation inhibition, and autophagy activation in ApoE<sup>-/-</sup> mice.

International immunopharmacology·2024
Same author

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies.

Blood·2024

mRNA display technology identifies drug-binding proteins from human tissues. This method successfully isolated FKBP12, a key FK506 binding protein, aiding drug discovery and receptor interaction studies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Identifying proteins that bind to small molecules is crucial for drug discovery.
  • Display technologies offer a powerful approach for screening proteome libraries.

Purpose of the Study:

  • To utilize mRNA display technology for the selection of proteins with affinity for a specific drug.
  • To characterize drug-receptor interactions and identify minimal binding domains.

Main Methods:

  • Construction of an mRNA-protein fusion library from human liver, kidney, and bone marrow transcripts.
  • Selection of binding proteins using an immobilized FK506-biotin conjugate.
  • Iterative rounds of selection to enrich for specific binding clones.

Related Experiment Videos

Main Results:

  • Three rounds of selection yielded full-length FKBP12 (FK506 binding protein 12 kDa) as the dominant clone.
  • The method was also applied to map the minimal drug-binding domain within FKBP12.
  • Successful identification of a specific protein-drug interaction.

Conclusions:

  • mRNA display is an effective method for identifying proteins that bind to small molecules.
  • This technology can be instrumental in discovering and characterizing new drug receptor interactions.
  • The approach facilitates the mapping of drug-binding domains, aiding in drug development.